Main > > >DIAGNOSTICS (CARDIO.) (C) *

Cardio.>Arrhytmia. Diagnostics. By Com-bining:
- Cloud-based Data Analytics
- Machine-Learning capabilities &
- Wearable Biosensing Technology
Company Goal: be the leading provider of first-line Ambulatory Electrocardiogram, or ECG, Monitoring for patients at risk for Arrhythmias.
EU Approval Date : 2014. 12.03.
USA Approval Date: 2012. 02.06.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 07.23.




Cardio.>Diagnostics. ElectroCardioGram (ECG). Remote Monitoring UnderGarment.
USA Approval Date: 2016. 12.01.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 03.31.




Cardio.>Diagnostics. Imaging. UltraSound (US)>>>
>About SubOptimal EchoCardiogram
Up to 20 percent of all resting
echocardiography studies and up to 30
percent of those conducted in critical
care patients can result in suboptimal
echocardiograms.3-6 A suboptimal image
is one in which two or more contiguous
left ventricular segments in any of the
three apical views cannot be
visualized.3,4,7 The use of contrast in
suboptimal echocardiograms may help
with clinical evaluation of the
patient.4,8
>Activation Device>Next G>USA Approval
Date: 2020. 08.12.
>Contrast Agent>Perflutren Lipid Micro-
sphere Inj.
>SubOptimal EchoCardiogram
ContraIndication>Shunt>REMOVED
USA>Approval Date: ?
(*) Company; Patents; TradeMarks & Web-
Site Available on Request.
UpDate: 2020. 09.08.




Cardio.>Diagnostics. Troponin. Ultra-Sensitive Troponin I Assay (cTnl).
Single Molecule Counting Technology.
EU Approval Date: 2017. 06.01.
(*) Company; Patents; & Web-Site
Available on Request.
UpDate: 2019. 04.01.




Diag. Medical. Computed Tomography (CT)
Imaging. Low Dose/Noise Software.
Approved in EU & USA
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 03.26.


>DIAGNOSTICS (CARDIO.) (C) *'s products
This section has no products